- Home
- PRFX vs APVO Comparison
PRFX vs APVO Comparison
Compare PRFX & APVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRFX
- APVO
- Stock Information
- Founded
- PRFX 2007
- APVO 2016
- Country
- PRFX Israel
- APVO United States
- Employees
- PRFX N/A
- APVO N/A
- Industry
- PRFX Biotechnology: Pharmaceutical Preparations
- APVO Biotechnology: Pharmaceutical Preparations
- Sector
- PRFX Health Care
- APVO Health Care
- Exchange
- PRFX Nasdaq
- APVO Nasdaq
- Market Cap
- PRFX 1.6M
- APVO 1.9M
- IPO Year
- PRFX 2020
- APVO N/A
- Fundamental
- Price
- PRFX $0.62
- APVO $0.16
- Analyst Decision
- PRFX Strong Buy
- APVO Strong Buy
- Analyst Count
- PRFX 1
- APVO 1
- Target Price
- PRFX $12.00
- APVO $8.00
- AVG Volume (30 Days)
- PRFX 238.9K
- APVO 660.7K
- Earning Date
- PRFX 11-13-2024
- APVO 11-12-2024
- Dividend Yield
- PRFX N/A
- APVO N/A
- EPS Growth
- PRFX N/A
- APVO N/A
- EPS
- PRFX N/A
- APVO N/A
- Revenue
- PRFX N/A
- APVO N/A
- Revenue This Year
- PRFX N/A
- APVO N/A
- Revenue Next Year
- PRFX N/A
- APVO N/A
- P/E Ratio
- PRFX N/A
- APVO N/A
- Revenue Growth
- PRFX N/A
- APVO N/A
- 52 Week Low
- PRFX $0.53
- APVO $0.14
- 52 Week High
- PRFX $20.16
- APVO $16.59
- Technical
- Relative Strength Index (RSI)
- PRFX 37.34
- APVO 33.91
- Support Level
- PRFX $0.53
- APVO $0.16
- Resistance Level
- PRFX $0.79
- APVO $0.15
- Average True Range (ATR)
- PRFX 0.06
- APVO 0.01
- MACD
- PRFX 0.04
- APVO 0.01
- Stochastic Oscillator
- PRFX 35.06
- APVO 49.13
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.